CD274 and neoplasm: TNBC has characteristics that may be associated with improved response to immune checkpoint inhibition, including increased mutational complexity13–16, higher PD-L1 expression17–21, and higher tumor infiltrating lymphocytes (TIL) compared to other breast cancer subtypes22–25.